Deutsche Bank Ag\ Obs Eva Sa Transaction History

Deutsche Bank Ag\

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 04, 2021	SELL	$2.47 - $3.34 $414,382 - $560,338	-167,766 Reduced 84.54%	30,689 $95,000
Q2 2021 Aug 11, 2021	BUY	$2.56 - $3.35 $423,280 - $553,902	165,344 Added 499.36%	198,455 $601,000
Q1 2021 May 13, 2021	SELL	$2.01 - $5.05 $38,175 - $95,914	-18,993 Reduced 36.45%	33,111 $107,000
Q4 2020 Feb 16, 2021	BUY	$1.89 - $2.55 $33,823 - $45,634	17,896 Added 52.32%	52,104 $109,000
Q3 2020 Nov 12, 2020	BUY	$2.46 - $6.15 $52,171 - $130,429	21,208 Added 163.14%	34,208 $85,000
Q2 2020 Aug 13, 2020	SELL	$2.01 - $5.95 $194,073 - $574,496	-96,554 Reduced 88.13%	13,000 $77,000
Q1 2020 May 14, 2020	BUY	$1.87 - $4.47 $158,912 - $379,860	84,980 Added 345.81%	109,554 $264,000
Q4 2019 Feb 14, 2020	BUY	$2.48 - $8.1 $28,703 - $93,749	11,574 Added 89.03%	24,574 $93,000
Q2 2019 Aug 14, 2019	BUY	$10.05 - $14.25 $96,480 - $136,800	9,600 Added 282.35%	13,000 $147,000
Q1 2019 May 15, 2019	BUY	$11.82 - $14.48 $40,176 - $49,217	3,399 Added 339900.0%	3,400 $43,000
Q4 2018 Feb 14, 2019	SELL	$10.8 - $17.94 $238,928 - $396,886	-22,123 Reduced 100.0%	1 $0
Q3 2018 Nov 14, 2018	BUY	$10.92 - $18.18 $117,095 - $194,944	10,723 Added 94.05%	22,124 $398,000
Q2 2018 Aug 14, 2018	BUY	$10.0 - $17.87 $114,010 - $203,735	11,401 New	11,401 $172,000

88K

Ticker OBSV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,499,200
Description
ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.